These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21846793)

  • 1. Elevated levels of active matrix metalloproteinase-9 cause hypertrophy in skeletal muscle of normal and dystrophin-deficient mdx mice.
    Dahiya S; Bhatnagar S; Hindi SM; Jiang C; Paul PK; Kuang S; Kumar A
    Hum Mol Genet; 2011 Nov; 20(22):4345-59. PubMed ID: 21846793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy.
    Li H; Mittal A; Makonchuk DY; Bhatnagar S; Kumar A
    Hum Mol Genet; 2009 Jul; 18(14):2584-98. PubMed ID: 19401296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice.
    Hindi SM; Shin J; Ogura Y; Li H; Kumar A
    PLoS One; 2013; 8(8):e72121. PubMed ID: 23977226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
    Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
    Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy.
    Dahiya S; Givvimani S; Bhatnagar S; Qipshidze N; Tyagi SC; Kumar A
    J Immunol; 2011 Sep; 187(5):2723-31. PubMed ID: 21810612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.
    Kumar A; Bhatnagar S; Kumar A
    Am J Pathol; 2010 Jul; 177(1):248-60. PubMed ID: 20472898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMP-10 is required for efficient muscle regeneration in mouse models of injury and muscular dystrophy.
    Bobadilla M; Sáinz N; Rodriguez JA; Abizanda G; Orbe J; de Martino A; García Verdugo JM; Páramo JA; Prósper F; Pérez-Ruiz A
    Stem Cells; 2014 Feb; 32(2):447-61. PubMed ID: 24123596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle.
    Blaauw B; Mammucari C; Toniolo L; Agatea L; Abraham R; Sandri M; Reggiani C; Schiaffino S
    Hum Mol Genet; 2008 Dec; 17(23):3686-96. PubMed ID: 18753145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).
    Fukushima K; Nakamura A; Ueda H; Yuasa K; Yoshida K; Takeda S; Ikeda S
    BMC Musculoskelet Disord; 2007 Jun; 8():54. PubMed ID: 17598883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-DNA array-based identification of transcription factor activities differentially regulated in skeletal muscle of normal and dystrophin-deficient mdx mice.
    Dogra C; Srivastava DS; Kumar A
    Mol Cell Biochem; 2008 May; 312(1-2):17-24. PubMed ID: 18278580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of omega-3 on matrix metalloproteinase-9, myoblast transplantation and satellite cell activation in dystrophin-deficient muscle fibers.
    de Carvalho SC; Hindi SM; Kumar A; Marques MJ
    Cell Tissue Res; 2017 Sep; 369(3):591-602. PubMed ID: 28623422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy.
    Li H; Mittal A; Paul PK; Kumar M; Srivastava DS; Tyagi SC; Kumar A
    J Biol Chem; 2009 Feb; 284(7):4439-50. PubMed ID: 19074147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
    Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
    Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential YAP nuclear signaling in healthy and dystrophic skeletal muscle.
    Iyer SR; Shah SB; Ward CW; Stains JP; Spangenburg EE; Folker ES; Lovering RM
    Am J Physiol Cell Physiol; 2019 Jul; 317(1):C48-C57. PubMed ID: 30995108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle progenitor cell proliferation during passive stretch of unweighted soleus in dystrophin deficient mice.
    Turtikova OV; Altaeva EG; Tarakina MV; Malashenko AM; Nemirovskaya TL; Shenkman BS
    J Gravit Physiol; 2007 Jul; 14(1):P95-6. PubMed ID: 18372716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy.
    Wehling-Henricks M; Jordan MC; Gotoh T; Grody WW; Roos KP; Tidball JG
    PLoS One; 2010 May; 5(5):e10763. PubMed ID: 20505827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice.
    Nakae Y; Stoward PJ; Kashiyama T; Shono M; Akagi A; Matsuzaki T; Nonaka I
    J Mol Histol; 2004 Jun; 35(5):489-99. PubMed ID: 15571326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiling in stably regenerating skeletal muscle of dystrophin-deficient mdx mice.
    Boer JM; de Meijer EJ; Mank EM; van Ommen GB; den Dunnen JT
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S118-24. PubMed ID: 12206806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suramin affects metalloproteinase-9 activity and increases β-dystroglycan levels in the diaphragm of the dystrophin-deficient mdx mouse.
    Taniguti AP; Matsumura CY; Rodrigues-Simioni L; Santo Neto H; Marques MJ
    Muscle Nerve; 2012 Nov; 46(5):810-3. PubMed ID: 23055317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.